Trial NCT02796144

View at ClinicalTrials.gov 
Org. Study IDs: 15-1998
Secondary IDs: 1R01DK105526-01A1

Last trial update was posted on 2021-03-03

MeSH Interventions

Metformin

MeSH Conditions

Overweight Psychotic Disorders Schizophrenia Weight Loss

Other Conditions

Schizoaffective Disorder

Stopping Reasons

The FDA advised of a possible health risk associated with lorcaserin and the drug is being withdrawn.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID